Health Cor Management, L.P. Chemo Centryx, Inc. Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $2.16 Million - $3.87 Million	140,630 Added 14.7%	1,097,370 $27.2 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $15.9 Million - $28 Million	716,210 Added 297.76%	956,740 $24 Million
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $4.42 Million - $9.74 Million	240,530 New	240,530 $8.76 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.